KaloBios (KBIO) Crumbles: Shkreli Arrested & Fired, Delisted And Board Members QuitRupert Hargreaves
KaloBios, the relatively unknown penny stock pharma company, which was on the verge of bankruptcy, hit the headlines after controversial figure Martin Shkreli took a large stake in the company and became its CEO, is falling apart as managers flee the sinking ship.
Prior to Shkreli's investment, at the beginning of December, KaloBios was running out of cash fast and had planned to shut down before the end of the year. However, Shkreli rode to the rescue of KaloBios with a $8.2 million . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.